An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
This treatment has been approved for sale to the public.
First Posted: July 7, 2009
Last Update Posted: November 30, 2016
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This treatment has been approved for sale to the public.|
|Study Completion Date:||No date given|
|Primary Completion Date:||June 2008 (Final data collection date for primary outcome measure)|